We are diligently and sustainably achieving
excellence in all that we do

Aurobindo Overview

Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.

Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.

Strengths and Leadership

  • Large manufacturing facilities approved by leading regulatory bodies
  • Large diversified product portfolio
  • Large R&D facility in India for formulations and active ingredients

Learn More

Operational Excellence

  • Vertical integration
  • Proven regulatory expertise
  • Technology and know-how for specialty formulations

Learn More

24000 +
Employees World Wide
155 +
Markets we are present
State-of-the-art manufacturing and packaging facilities globally
40+ Billion
Dosage Forms